Market revenue in 2023 | USD 310.4 million |
Market revenue in 2030 | USD 745.8 million |
Growth rate | 13.3% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 51.87% in 2023. Horizon Databook has segmented the Latin America structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America structured heart devices market is undergoing remarkable growth, primarily fueled by the region's escalating burden of CVDs and aortic valve disorders stemming from evolving lifestyle patterns, rapid urbanization, and an aging demographic.
Recent industry data underscores a surge in demand for advanced cardiac interventions, notably TAVR procedures, as healthcare systems across Latin American nations strive to address the burgeoning healthcare needs of their populations.
Moreover, the Latin American Society of Interventional Cardiology's publication of the Latin American Clinical Guidelines on TAVR versus SAVR for severe aortic stenosis patients in the prestigious Heart BMJ Journal reflects a significant milestone, indicative of collaborative efforts between SOLACI and the Interamerican Society of Cardiology.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America structural heart devices market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account